Indications and uses
- cure most jock itch (tinea cruris) and ringworm (tinea corporis) - relieves itching, burning, cracking andf scaling which accompany this condition
- cure most jock itch (tinea cruris) and ringworm (tinea corporis) - relieves itching, burning, cracking andf scaling which accompany this condition
- adults and children 12 years and over: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor on the bottom or sides of the foot: appl...
Terbinafine hydrochloride 1%
Antifungal
- cure most jock itch (tinea cruris) and ringworm (tinea corporis)
- relieves itching, burning, cracking andf scaling which accompany this condition
For external use only
Do not use
- on nails or scalp
- in or near the mouth or eyes
- for vaginal yeast infections
When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water
Stop use and ask a doctor if too much irritation occurs or gets worse
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
- adults and children 12 years and over:
- children under 12 years: ask a doctor
- do no use if seal on tube is broken or is not visible
- store at controlled room temperature 20-25C (68-77F)
benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearly alcohol
call 1-800-330-9876
Lamisil AT
Cream Terbinafine Hydrochloride Cream 1% - Antifungal
For JOCK ITCH
- cures most jock itch
- for effective relief of itching and burning
NET WT
12 g (0.42 oz)
Lamisil AT Cream
Terbinafine Hydrochloride Cream 1% - Antifungal
For Athlete's Foot
Net Wt
12 g (0.42 oz)
Lamisil AT Cream
Terbinafine Hydrochloride Cream 1% - Antifungal
For Athlete's Foot
NET WT
30 g (1 oz)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 992530 | LamISIL AT 1 % Topical Cream | PSN | 6 |
| 992528 | terbinafine HCl 1 % Topical Cream | PSN | 6 |
| 992530 | terbinafine hydrochloride 10 MG/ML Topical Cream [Lamisil] | SBD | 6 |
| 992528 | terbinafine hydrochloride 10 MG/ML Topical Cream | SCD | 6 |
| 992530 | Lamisil 10 MG/ML Topical Cream | SY | 6 |
| 992530 | Lamisil AT 1 % Topical Cream | SY | 6 |
| 992528 | terbinafine hydrochloride 1 % Topical Cream | SY | 6 |
| Class | Version | Type | Effective |
|---|---|---|---|
| TERBINAFINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0300673998308 | GTIN-13: 0300673998308 EAN-13: 0300673998308 GTIN-12: 300673998308 UPC-A: 300673998308 GTIN storage (14 digits): 00300673998308 | LamisilFoot_30g_1OZ_Carton13508.jpg |
| Barcode | EAN-13 | 0300673998421 | GTIN-13: 0300673998421 EAN-13: 0300673998421 GTIN-12: 300673998421 UPC-A: 300673998421 GTIN storage (14 digits): 00300673998421 | LamisilFoot_12g_0.42OZ_Carton13509.jpg |
| Barcode | EAN-13 | 0300673999428 | GTIN-13: 0300673999428 EAN-13: 0300673999428 GTIN-12: 300673999428 UPC-A: 300673999428 GTIN storage (14 digits): 00300673999428 | LamisilJock_12g_0.42OZ_Carton13510.jpg |
| Data code | Data Matrix | 13230 | LamisilFoot_30g_1OZ_WLabel13230.jpg | |
| Data code | Data Matrix | 13307 | LamisilJock_12g_0.42OZ_WLabel13307R.jpg | |
| Data code | Data Matrix | 13508 | LamisilFoot_30g_1OZ_Carton13508.jpg | |
| Data code | Data Matrix | 13509 | LamisilFoot_12g_0.42OZ_Carton13509.jpg | |
| Data code | Data Matrix | 13510 | LamisilJock_12g_0.42OZ_Carton13510.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 55a24767-1759-5f6a-8888-ea4aa0adac21 | Product name | 1 | 20140508 |
| db9701af-cb4f-b8ba-d282-6bc5b6b7c467 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61047-120-01 | Lamisil AT Cream | 1 in 1 CARTON | CREAM | 1 | 6 | |
| 61047-120-01 | Lamisil AT Cream | 12 g in 1 TUBE | CREAM | 12 | 6 | |
| 61047-120-02 | Lamisil AT Cream | 12 g in 1 TUBE | CREAM | 12 | 6 | |
| 61047-120-02 | Lamisil AT Cream | 1 in 1 CARTON | CREAM | 1 | 6 | |
| 61047-120-03 | Lamisil AT Cream | 1 in 1 CARTON | CREAM | 1 | 6 | |
| 61047-120-03 | Lamisil AT Cream | 30 g in 1 TUBE | CREAM | 30 | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61047-120 | 61047-120-01, 61047-120-02, 61047-120-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CETYL PALMITATE | 5ZA2S6B08X | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| SORBITAN MONOSTEARATE | NVZ4I0H58X | IACT |
| TERBINAFINE HYDROCHLORIDE | 012C11ZU6G | ACTIB |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| POLYSORBATE 60 | CAL22UVI4M | IACT |
| STEARYL ALCOHOL | 2KR89I4H1Y | IACT |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 4 | 2025-05-29 | full-release | 2026-06-01 01:01:51 |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020980-001 | LAMISIL | TERBINAFINE HYDROCHLORIDE | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N020980-001 | LAMISIL | 1% | CREAM / TOPICAL | RLD, RS | 1999-03-09 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamisil AT Cream | TERBINAFINE HYDROCHLORIDE | Voyant Beauty Inc. | 9dea4789-bf1c-1577-e053-2a95a90a5381 | 2025-11-18 | Warnings | 61047-120-03 61047-120-02 61047-120-01 61047-120 61047012002 61047012001 61047012003 43e44bcd-a7df-399e-e063-6394a90a65a3 9dea4789-bf1c-1577-e053-2a95a90a5381 |
Adverse event summaries are temporarily unavailable. Other product information remains available.